~~<i id='F600EB26CB'><strike id='F600EB26CB'><tt id='F600EB26CB'><pre id='F600EB26CB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

knowledge

author：hotspot 2025-09-08 08:49:59 - browse：61

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Biotech lab space demand falls sharply

explore

leisure time

explore

entertainment

explore

knowledge

AdobeWeneverwalkalone.Acrossthelandscapeofourbodies,trillionsofmicrobesaccompanyusonthejourneyoflife

WSS

Medical student insurance fails on mental health care coverage

Second xenotransplant done with gene

It's been 20 years since Dolly the sheep. Where's my clone?

Why are Kaiser Permanente staff considering a strike?

Readout LOUD podcast: possible new ALS drug, artificial wombs

Drug for rare kidney disease narrowly misses mark in clinical trial

entertainment

knowledge

explore

Hepatitis C has a cure — but many Americans still lack access to it

STAT Virtual Event: Putting AI to the Test

Jerome Adams on the need for new antivirals for Covid

It's been 20 years since Dolly the sheep. Where's my clone?

New air purifier tech could be key to improving indoor air quality

Emergency workers more likely to restrain Black patients: study

ChatGPT in medicine: STAT answers readers' burning questions

CommonSpirit Health keeps growing, even as it loses money

Novavax promises a turnaround & Lilly roils the obesity market

Ukraine and a new approach to mental health in war

leisure time

Why are Kaiser Permanente staff considering a strike?

Microbiome research is starting to find links to chronic diseases

Why are Kaiser Permanente staff considering a strike?

EpiPen alternative approval delay highlights citizen petition issue

Second xenotransplant done with gene

How Vertex's cystic fibrosis drug is changing patients' lives

explore

entertainment

explore

knowledge